Seroatlas · Human Serome Atlas

LDHD

Probable D-lactate dehydrogenase, mitochondrial

Also known as: LDHD_HUMAN

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
Q86WU2
Gene
LDHD
Ensembl
ENSG00000166816
Chromosome
16
Canonical length
507 aa
Protein class
Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins
Subcellular location
Cytosol
Quaternary structure
Homooligomer

OverviewNCBI Gene

The protein encoded by this gene belongs to the D-isomer specific 2-hydroxyacid dehydrogenase family. The similar protein in yeast has both D-lactate and D-glycerate dehydrogenase activities. Alternative splicing occurs at this locus and two transcript variants encoding distinct isoforms have been identified. [provided by RefSeq, Jul 2008]

Canonical amino-acid sequenceUniProt

507 residues, UniProt reviewed canonical sequence.

>Q86WU2|LDHD
     1  MARLLRSATW ELFPWRGYCS QKAKGELCRD FVEALKAVVG GSHVSTAAVV REQHGRDESV
    61  HRCEPPDAVV WPQNVEQVSR LAALCYRQGV PIIPFGTGTG LEGGVCAVQG GVCVNLTHMD
   121  RILELNQEDF SVVVEPGVTR KALNAHLRDS GLWFPVDPGA DASLCGMAAT GASGTNAVRY
   181  GTMRDNVLNL EVVLPDGRLL HTAGRGRHFR FGFWPEIPHH TAWYSPCVSL GRRKSAAGYN
   241  LTGLFVGSEG TLGLITATTL RLHPAPEATV AATCAFPSVQ AAVDSTVHIL QAAVPVARIE
   301  FLDEVMMDAC NRYSKLNCLV APTLFLEFHG SQQALEEQLQ RTEEIVQQNG ASDFSWAKEA
   361  EERSRLWTAR HNAWYAALAT RPGCKGYSTD VCVPISRLPE IVVQTKEDLN ASGLTGSIVG
   421  HVGDGNFHCI LLVNPDDAEE LGRVKAFAEQ LGRRALALHG TCTGEHGIGM GKRQLLQEEV
   481  GAVGVETMRQ LKAVLDPQGL MNPGKVL

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against LDHD can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Intracellular
Secreted
No
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.26
Highest tissue expression
126 nTPM

Expression across tissuesHPA

Tissue

  • liver: 126 nTPM
  • heart muscle: 79 nTPM
  • skeletal muscle: 64 nTPM
  • choroid plexus: 58 nTPM
  • tongue: 49 nTPM
  • kidney: 35 nTPM

Single-cell type

  • hepatocytes: 95 nCPM
  • colonocytes: 73 nCPM
  • parietal cells: 58 nCPM
  • breast lactating cells: 51 nCPM
  • esophageal apical cells: 41 nCPM
  • foveolar cells: 24 nCPM

Immune cell

  • basophil: 11 nTPM
  • non-classical monocyte: 4.8 nTPM
  • intermediate monocyte: 3.6 nTPM
  • classical monocyte: 2.2 nTPM
  • total PBMC: 0.8 nTPM
  • eosinophil: 0.6 nTPM

Brain region

  • choroid plexus: 60 nTPM
  • pons: 34 nTPM
  • medulla oblongata: 32 nTPM
  • cerebellum: 31 nTPM
  • midbrain: 31 nTPM
  • basal ganglia: 29 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about LDHD.

Disease | AllUniProt

Conditions LDHD is implicated in, by any mechanism.

Disease | GeneticClinVar

8 pathogenic / likely-pathogenic of 120 ClinVar records.

Conditions with pathogenic or likely-pathogenic variants.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
1.22
gnomAD pLI
0
gnomAD missense Z
0.43
DepMap mean gene effect
-0.07
DepMap dependency class
selective

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

  • lactate catabolic process

Molecular functions

  • FAD binding
  • flavin adenine dinucleotide binding
  • (2R)-2-hydroxycarboxylate dehydrogenase activity
  • D-lactate dehydrogenase (cytochrome) activity
  • D-lactate dehydrogenase (FAD) activity
  • D-lactate dehydrogenase (NAD+) activity
  • lactate dehydrogenase activity

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of LDHD in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads LDHD as an antibody target. Whether an autoantibody or antibody against LDHD could matter depends on whether native LDHD is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

LDHD is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label LDHD as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/LDHD. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...